Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$24.32 - $75.3 $308,936 - $956,535
-12,703 Reduced 2.52%
490,585 $36.9 Million
Q1 2022

May 13, 2022

SELL
$24.73 - $51.25 $1.79 Million - $3.7 Million
-72,200 Reduced 12.55%
503,288 $13.5 Million
Q4 2021

Feb 10, 2022

BUY
$35.48 - $67.33 $1.95 Million - $3.69 Million
54,863 Added 10.54%
575,488 $27.5 Million
Q2 2021

Jul 20, 2021

BUY
$62.93 - $90.59 $4.01 Million - $5.77 Million
63,684 Added 13.94%
520,625 $40.6 Million
Q1 2021

Apr 29, 2021

SELL
$88.19 - $140.01 $440 - $700
-5 Reduced -0.0%
456,941 $53.5 Million
Q4 2020

Jan 22, 2021

BUY
$87.69 - $130.94 $19.4 Million - $29 Million
221,783 Added 94.31%
456,946 $55.7 Million
Q3 2020

Oct 19, 2020

SELL
$56.99 - $89.33 $166,296 - $260,664
-2,918 Reduced 1.23%
235,163 $20.5 Million
Q2 2020

Jul 23, 2020

BUY
$39.94 - $70.39 $3.41 Million - $6.01 Million
85,441 Added 55.98%
238,081 $15.4 Million
Q1 2020

May 26, 2020

BUY
$32.02 - $66.17 $384 - $794
12 Added 0.01%
152,640 $9.3 Million
Q4 2019

Jan 21, 2020

BUY
$35.56 - $63.25 $4.25 Million - $7.57 Million
119,628 Added 362.51%
152,628 $10,000
Q3 2019

Oct 21, 2019

BUY
$36.9 - $57.76 $1.22 Million - $1.91 Million
33,000 New
33,000 $1,000

About Turning Point Therapeutics, Inc.


  • Ticker TPTX
  • Exchange NASDAQ
  • Shares Outstandng 50,074,300
More about TPTX
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.